GlassScriptPhysician profile
Mark L Lesh
NPI 1083786255
$5,412.62
in general payments reported to CMS, 2019-2025
11 companies · $783 in 2025
The $783 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2021: $429 · 2022: $694 · 2023: $1,793 · 2024: $1,502 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,941 · Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,941.04 |
| Food and Beverage | $1,137.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,837.36 | 2022-2025 | |
| Cdc Medical LLC | $293.71 | 2023-2024 | |
| Depuy Synthes Sales INC. | $290.29 | 2022-2024 | Na |
| Si-Bone, INC. | $216.72 | 2021 | |
| Stryker Corporation | $214.95 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $195.90 | 2019-2021 | |
| Heron Therapeutics, INC. | $179.66 | 2022-2025 | Zynrelef |
| Pacira Therapeutics, INC. | $108.05 | 2019 | |
| Conmed Corporation | $37.32 | 2022 | |
| Vericel Corporation | $21.37 | 2022 | |
| Spr Therapeutics, INC | $17.29 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.